Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PLK1 | P53350 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28717468 | 0.73 | HDAC6 (0.38) | KIF11ALDH1A1TSHRBACE1POLB | |
| SCHEMBL11133165 | 0.69 | MKNK1 (0.46) | KIF11ALDH1A1POLBMAPTL3MBTL1 | |
| Biphenyl SCHEMBL28313556 | 0.68 | ALDH1A1 (0.60) | KIF11ALDH1A1TSHRCYP1A2MAPT | |
| SCHEMBL17161166 | 0.67 | KIF11 (0.40) | KIF11ALDH1A1TSHRBACE1L3MBTL1 | |
| SCHEMBL28820647 | 0.67 | PTGS2 (0.57) | ALDH1A1CYP1A2CYP2D6MAPTCYP2C19 | |
| SCHEMBL6830008 | 0.66 | — | — | |
| Biphenyl SCHEMBL27543247 | 0.64 | ALDH1A1 (0.64) | KIF11ALDH1A1TSHRBACE1CYP1A2 | |
| SCHEMBL1224397 | 0.64 | MAPT (0.56) | ALDH1A1CYP1A2CYP2D6MAPTCYP2C19 | |
| SCHEMBL2597832 | 0.63 | FABP4 (0.53) | KIF11ALDH1A1TSHRPOLBMAPT | |
| Biphenyl SCHEMBL27647615 | 0.62 | ALDH1A1 (0.60) | KIF11ALDH1A1TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119037-B2 | Square planar transition metal complexes and organic semiconductive materials using them as well as electronic or optoelectric components | NOVALED AG (DE) | 2012-02-21 | — | — | US | disclosed |
| US-8119037-B2 | Square planar transition metal complexes and organic semiconductive materials using them as well as electronic or optoelectric components | NOVALED AG (DE) | 2012-02-21 | — | — | US | disclosed |
| US-20100096600-A1 | Square Planar Transition Metal Complexes and Organic Semiconductive Materials Using Them as Well as Electronic or Optoelectric Components | NOVALED AG (DE) | 2010-04-22 | — | — | US | disclosed |
| US-20100096600-A1 | Square Planar Transition Metal Complexes and Organic Semiconductive Materials Using Them as Well as Electronic or Optoelectric Components | NOVALED AG (DE) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100096600-A1 | Square Planar Transition Metal Complexes and Organic Semiconductive Materials Using Them as Well as Electronic or Optoelectric Components | ORC3, OSTC, OR10J3 | KIF11 1198/4885ALDH1A1 3661/4885TSHR 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.